<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02897661</url>
  </required_header>
  <id_info>
    <org_study_id>NEU-CN-160814</org_study_id>
    <nct_id>NCT02897661</nct_id>
  </id_info>
  <brief_title>Fecal Microbiota Transplantation Improves Nutritional State of Patients With Crohn's Disease</brief_title>
  <official_title>Fecal Microbiota Transplantation Combined Enteral Nutrition Therapy Contribute to Nutritional Improvement of Patients With Crohns' Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Second Hospital of Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Second Hospital of Nanjing Medical University</source>
  <brief_summary>
    <textblock>
      Patients with Crohns' disease are always complicated with malnutrition. This trial aimed to
      assess whether FMT accompanied by enteral nutrition (EN) can make contributions to patients
      with Crohns' disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in nutritional index</measure>
    <time_frame>Day 8</time_frame>
    <description>albumin and prealbumin in g/L</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in nutritional index</measure>
    <time_frame>Day 15</time_frame>
    <description>albumin and prealbumin in g/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in inflammation markers</measure>
    <time_frame>Day 15</time_frame>
    <description>C-reactive protein in mg/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in inflammation index</measure>
    <time_frame>Day 15</time_frame>
    <description>Erythrocyte Sedimentation Rate in mm/h</description>
  </secondary_outcome>
  <other_outcome>
    <measure>adverse events</measure>
    <time_frame>two weeks</time_frame>
    <description>aspiration of different gastric content, infection and allergy, etc.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Crohn's Diseases</condition>
  <arm_group>
    <arm_group_label>MNZ plus Early FMT and EN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metronidazole+EN (day-3~-1), FMT (day1), EN (day1-14)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MNZ plus late FMT and EN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metronidazole+EN (day-3~-1), FMT (day8), EN (day1-14)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Early FMT plus EN</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EN (day-3~-1), FMT (day1), EN (day1-14)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FMT</intervention_name>
    <description>fecal microbiota transplantation (FMT) via mid-GI</description>
    <arm_group_label>MNZ plus Early FMT and EN</arm_group_label>
    <arm_group_label>MNZ plus late FMT and EN</arm_group_label>
    <arm_group_label>Early FMT plus EN</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metronidazole</intervention_name>
    <description>oral adminstration</description>
    <arm_group_label>MNZ plus Early FMT and EN</arm_group_label>
    <arm_group_label>MNZ plus late FMT and EN</arm_group_label>
    <other_name>Methyl-5-nitroimidazole-1-ethanol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>EN</intervention_name>
    <description>via nasal feeding tube</description>
    <arm_group_label>MNZ plus Early FMT and EN</arm_group_label>
    <arm_group_label>MNZ plus late FMT and EN</arm_group_label>
    <arm_group_label>Early FMT plus EN</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. patients aged from 18 to 65, regardless of gender;

          2. moderate to severe active CD patients(CDAI＞220)，accompanied with malnutrition;

          3. infection status;

          4. patients with high compliance;

          5. suitable for fecal microbiota transplantation and enteral nutrition therapy;

          6. history of safe mesalazine use.

        Exclusion Criteria:

          1. severe infection which affected vital signs;

          2. parenteral infection such as urinary tract, lung and so on;

          3. mycobacterium tuberculosis infection;

          4. immunosuppressor or biologicals use within 6 week;

          5. allergic to metronidazole,salicylic acid preparation, etc;

          6. complicated with perianal Crohn's disease, intestinal fistula, intestinal obstruction;

          7. accompanied by any severe disease such as cancer or AIDS;

          8. patients who are in pregnant or going to pregnant;

          9. patients who has disability mentally and physically.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Faming Zhang, associate chief physician</last_name>
    <role>Study Chair</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Faming Zhang, associate chief physician</last_name>
    <phone>15005160838</phone>
    <email>fzhang@njmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faming Zhang, MD, PhD</last_name>
      <phone>086-25-58509883</phone>
      <email>fzhang@njmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Tjellström B, Högberg L, Stenhammar L, Magnusson KE, Midtvedt T, Norin E, Sundqvist T. Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease. Scand J Gastroenterol. 2012 Dec;47(12):1454-9. doi: 10.3109/00365521.2012.703234. Epub 2012 Sep 28.</citation>
    <PMID>23016828</PMID>
  </reference>
  <reference>
    <citation>Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, Armstrong D, Marshall JK, Kassam Z, Reinisch W, Lee CH. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 2015 Jul;149(1):102-109.e6. doi: 10.1053/j.gastro.2015.04.001. Epub 2015 Apr 7.</citation>
    <PMID>25857665</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2016</study_first_submitted>
  <study_first_submitted_qc>September 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2016</study_first_posted>
  <last_update_submitted>January 26, 2017</last_update_submitted>
  <last_update_submitted_qc>January 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Second Hospital of Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Faming Zhang</investigator_full_name>
    <investigator_title>Associate professor, Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>fecal microbiota transplantation</keyword>
  <keyword>enteral nutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metronidazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

